180 related articles for article (PubMed ID: 15935664)
1. A three-residue, continuous binding epitope peptidomimetic of ShK toxin as a Kv1.3 inhibitor.
Harvey AJ; Gable RW; Baell JB
Bioorg Med Chem Lett; 2005 Jul; 15(13):3193-6. PubMed ID: 15935664
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of the sea anemone toxin ShK recognizing the Kv1.3 channel explored by docking and molecular dynamic simulations.
Jin L; Wu Y
J Chem Inf Model; 2007; 47(5):1967-72. PubMed ID: 17718553
[TBL] [Abstract][Full Text] [Related]
3. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of type-III mimetics of ShK toxin.
Baell JB; Harvey AJ; Norton RS
J Comput Aided Mol Des; 2002 Apr; 16(4):245-62. PubMed ID: 12400855
[TBL] [Abstract][Full Text] [Related]
5. Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile.
Middleton RE; Sanchez M; Linde AR; Bugianesi RM; Dai G; Felix JP; Koprak SL; Staruch MJ; Bruguera M; Cox R; Ghosh A; Hwang J; Jones S; Kohler M; Slaughter RS; McManus OB; Kaczorowski GJ; Garcia ML
Biochemistry; 2003 Nov; 42(46):13698-707. PubMed ID: 14622016
[TBL] [Abstract][Full Text] [Related]
6. Designed peptide analogues of the potassium channel blocker ShK toxin.
Lanigan MD; Pennington MW; Lefievre Y; Rauer H; Norton RS
Biochemistry; 2001 Dec; 40(51):15528-37. PubMed ID: 11747428
[TBL] [Abstract][Full Text] [Related]
7. Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocytes and rat brain.
Pennington MW; Mahnir VM; Krafte DS; Zaydenberg I; Byrnes ME; Khaytin I; Crowley K; Kem WR
Biochem Biophys Res Commun; 1996 Feb; 219(3):696-701. PubMed ID: 8645244
[TBL] [Abstract][Full Text] [Related]
8. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
Mouhat S; Mosbah A; Visan V; Wulff H; Delepierre M; Darbon H; Grissmer S; De Waard M; Sabatier JM
Biochem J; 2004 Jan; 377(Pt 1):25-36. PubMed ID: 12962541
[TBL] [Abstract][Full Text] [Related]
9. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
[TBL] [Abstract][Full Text] [Related]
10. Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin.
Pennington MW; Lanigan MD; Kalman K; Mahnir VM; Rauer H; McVaugh CT; Behm D; Donaldson D; Chandy KG; Kem WR; Norton RS
Biochemistry; 1999 Nov; 38(44):14549-58. PubMed ID: 10545177
[TBL] [Abstract][Full Text] [Related]
11. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin.
Rauer H; Pennington M; Cahalan M; Chandy KG
J Biol Chem; 1999 Jul; 274(31):21885-92. PubMed ID: 10419508
[TBL] [Abstract][Full Text] [Related]
12. The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.
Beeton C; Smith BJ; Sabo JK; Crossley G; Nugent D; Khaytin I; Chi V; Chandy KG; Pennington MW; Norton RS
J Biol Chem; 2008 Jan; 283(2):988-97. PubMed ID: 17984097
[TBL] [Abstract][Full Text] [Related]
13. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.
Baell JB; Gable RW; Harvey AJ; Toovey N; Herzog T; Hänsel W; Wulff H
J Med Chem; 2004 Apr; 47(9):2326-36. PubMed ID: 15084131
[TBL] [Abstract][Full Text] [Related]
14. Affinity and selectivity of ShK toxin for the Kv1 potassium channels from free energy simulations.
Rashid MH; Kuyucak S
J Phys Chem B; 2012 Apr; 116(16):4812-22. PubMed ID: 22480371
[TBL] [Abstract][Full Text] [Related]
15. Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3.
Lanigan MD; Kalman K; Lefievre Y; Pennington MW; Chandy KG; Norton RS
Biochemistry; 2002 Oct; 41(40):11963-71. PubMed ID: 12356296
[TBL] [Abstract][Full Text] [Related]
16. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
[TBL] [Abstract][Full Text] [Related]
17. Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases.
Chhabra S; Chang SC; Nguyen HM; Huq R; Tanner MR; Londono LM; Estrada R; Dhawan V; Chauhan S; Upadhyay SK; Gindin M; Hotez PJ; Valenzuela JG; Mohanty B; Swarbrick JD; Wulff H; Iadonato SP; Gutman GA; Beeton C; Pennington MW; Norton RS; Chandy KG
FASEB J; 2014 Sep; 28(9):3952-64. PubMed ID: 24891519
[TBL] [Abstract][Full Text] [Related]
18. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.
Pennington MW; Harunur Rashid M; Tajhya RB; Beeton C; Kuyucak S; Norton RS
FEBS Lett; 2012 Nov; 586(22):3996-4001. PubMed ID: 23063513
[TBL] [Abstract][Full Text] [Related]
19. Potent Kv1.3 inhibitors from correolide-modification of the C18 position.
Bao J; Miao S; Kayser F; Kotliar AJ; Baker RK; Doss GA; Felix JP; Bugianesi RM; Slaughter RS; Kaczorowski GJ; Garcia ML; Ha SN; Castonguay L; Koo GC; Shah K; Springer MS; Staruch MJ; Parsons WH; Rupprecht KM
Bioorg Med Chem Lett; 2005 Jan; 15(2):447-51. PubMed ID: 15603971
[TBL] [Abstract][Full Text] [Related]
20. Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseases.
Norton RS; Pennington MW; Wulff H
Curr Med Chem; 2004 Dec; 11(23):3041-52. PubMed ID: 15578998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
